Published in Aust N Z J Psychiatry on November 09, 2012
Antipsychotics, mood stabilisers, and risk of violent crime. Lancet (2014) 4.25
Torsadogenic risk of antipsychotics: combining adverse event reports with drug utilization data across Europe. PLoS One (2013) 1.13
RUNX3 suppresses migration, invasion and angiogenesis of human renal cell carcinoma. PLoS One (2013) 0.94
Use of benzodiazepines and related drugs in Manitoba: a population-based study. CMAJ Open (2014) 0.92
Depressive Symptoms before and after Treatment of Obstructive Sleep Apnea in Men and Women. J Clin Sleep Med (2015) 0.87
Gender and injuries predict stimulant medication use. J Child Adolesc Psychopharmacol (2014) 0.84
Over-diagnosed and over-treated: a survey of Australian public attitudes towards the acceptability of drug treatment for depression and ADHD. BMC Psychiatry (2014) 0.83
Workplace risk factors for anxiety and depression in male-dominated industries: a systematic review. Health Psychol Behav Med (2014) 0.81
Concerns about quetiapine. Aust Prescr (2015) 0.81
Factors associated with antidepressant, anxiolytic, and other psychotropic medication use to treat psychiatric symptoms in the city of São Paulo, Brazil. Int Clin Psychopharmacol (2014) 0.78
Antidepressant use and risk of cardiovascular outcomes in people aged 20 to 64: cohort study using primary care database. BMJ (2016) 0.78
Antipsychotic drugs in pregnancy: a review of their maternal and fetal effects. Ther Adv Drug Saf (2014) 0.78
Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study. BMC Fam Pract (2014) 0.77
Impact of acute administration of escitalopram on the processing of emotional and neutral images: a randomized crossover fMRI study of healthy women. J Psychiatry Neurosci (2014) 0.76
Identifying cross-cultural variations in psychostimulant use for attention deficit hyperactivity disorder using linked data. Child Adolesc Psychiatry Ment Health (2017) 0.75
Quo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context. Int J Mol Sci (2015) 0.75
Trends in the use of antipsychotics in the Israeli inpatient population, 2004-2013. Isr J Health Policy Res (2016) 0.75
Has increased provision of treatment reduced the prevalence of common mental disorders? Review of the evidence from four countries. World Psychiatry (2017) 0.75
Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series. Glob Adv Health Med (2015) 0.75
Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta. Int J Exp Pathol (2016) 0.75
Risk of Fetal Death after Treatment with Antipsychotic Medications during Pregnancy. PLoS One (2015) 0.75
"It has to be fixed": a qualitative inquiry into perceived ADHD behaviour among affected individuals and parents in Western Australia. BMC Health Serv Res (2016) 0.75
Outcome reporting bias in randomized-controlled trials investigating antipsychotic drugs. Transl Psychiatry (2017) 0.75
Trends in treatment with antipsychotic medication in relation to national directives, in people with dementia - a review of the Swedish context. BMC Psychiatry (2017) 0.75
Psychotropic polypharmacy in Australia, 2006 to 2015: a descriptive cohort study. Br J Clin Pharmacol (2017) 0.75
The effects of predator odors in mammalian prey species: a review of field and laboratory studies. Neurosci Biobehav Rev (2005) 2.98
Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology (Berl) (2011) 1.84
TMT-induced autonomic and behavioral changes and the neural basis of its processing. Neurosci Biobehav Rev (2005) 1.69
Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats. J Psychopharmacol (2004) 1.67
Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure. Neuropsychopharmacology (2007) 1.47
On the anxiogenic and anxiolytic nature of long-term cerebral 5-HT depletion following MDMA. Psychopharmacology (Berl) (2002) 1.45
Systemically administered oxytocin decreases methamphetamine activation of the subthalamic nucleus and accumbens core and stimulates oxytocinergic neurons in the hypothalamus. Addict Biol (2010) 1.43
Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol (2011) 1.41
Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats. J Psychopharmacol (2006) 1.34
Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA. ACS Chem Neurosci (2015) 1.15
Analysis of cannabis seizures in NSW, Australia: cannabis potency and cannabinoid profile. PLoS One (2013) 1.12
High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: neural consequences and comparison with methamphetamine. J Psychopharmacol (2013) 1.12
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice. Int J Neuropsychopharmacol (2009) 1.03
A meta-analysis on the impact of alcohol dependence on short-term resting-state heart rate variability: implications for cardiovascular risk. Alcohol Clin Exp Res (2012) 1.03
Oxytocin decreases methamphetamine self-administration, methamphetamine hyperactivity, and relapse to methamphetamine-seeking behaviour in rats. Neuropharmacology (2009) 1.02
Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor. Neuropsychopharmacology (2013) 1.02
Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology (2005) 1.00
Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol (2003) 1.00
Consumption of high carbohydrate, high fat, and normal chow is equally suppressed by a cannabinoid receptor antagonist in non-deprived rats. Neurosci Lett (2004) 0.97
Repeated weekly exposure to MDMA, methamphetamine or their combination: long-term behavioural and neurochemical effects in rats. Drug Alcohol Depend (2006) 0.95
Adolescent oxytocin exposure causes persistent reductions in anxiety and alcohol consumption and enhances sociability in rats. PLoS One (2011) 0.95
Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol Clin Exp Res (2007) 0.95
Cyclooxygenase-2 in the pathogenesis of murine cerebral malaria. J Infect Dis (2004) 0.95
MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. Psychopharmacology (Berl) (2004) 0.93
Intermittent access to beer promotes binge-like drinking in adolescent but not adult Wistar rats. Alcohol (2009) 0.93
Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion. Eur J Pharmacol (2002) 0.93
Chronic fluoxetine treatment partly attenuates the long-term anxiety and depressive symptoms induced by MDMA ('Ecstasy') in rats. Neuropsychopharmacology (2004) 0.92
Neural activation during cat odor-induced conditioned fear and 'trial 2' fear in rats. Neurosci Biobehav Rev (2005) 0.92
A brief history of oxytocin and its role in modulating psychostimulant effects. J Psychopharmacol (2013) 0.92
Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion. PLoS One (2012) 0.90
Oxytocin directly administered into the nucleus accumbens core or subthalamic nucleus attenuates methamphetamine-induced conditioned place preference. Behav Brain Res (2011) 0.89
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoids. Int J Neuropsychopharmacol (2010) 0.88
The cannabinoid receptor antagonist SR 141716 attenuates overfeeding induced by systemic or intracranial morphine. Psychopharmacology (Berl) (2003) 0.88
Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res (2006) 0.87
High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. J Psychopharmacol (2008) 0.87
Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats. Neuropharmacology (2004) 0.87
Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol (2003) 0.87
Serotonin (1A) receptor involvement in acute 3,4-methylenedioxymethamphetamine (MDMA) facilitation of social interaction in the rat. Prog Neuropsychopharmacol Biol Psychiatry (2005) 0.87
Heart rate variability predicts alcohol craving in alcohol dependent outpatients: further evidence for HRV as a psychophysiological marker of self-regulation. Drug Alcohol Depend (2013) 0.87
Proteomic analysis demonstrates adolescent vulnerability to lasting hippocampal changes following chronic alcohol consumption. Alcohol Clin Exp Res (2008) 0.87
MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research. Drug Alcohol Rev (2007) 0.87
The dopamine receptor antagonist SCH 23390 attenuates feeding induced by Delta9-tetrahydrocannabinol. Brain Res (2004) 0.86
Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors. Psychopharmacology (Berl) (2005) 0.85
Predatory threat induces huddling in adolescent rats and residual changes in early adulthood suggestive of increased resilience. Behav Brain Res (2011) 0.85
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescence. Int J Neuropsychopharmacol (2012) 0.85
Perinatal exposure to delta(9)-tetrahydrocannabinol alters heroin-induced place conditioning and fos-immunoreactivity. Neuropsychopharmacology (2006) 0.85
Protein expression profile in the amygdala of rats with methamphetamine-induced behavioral sensitization. Neurosci Lett (2008) 0.84
Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats. Neuropsychopharmacology (2005) 0.84
Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: a model of adverse antidepressant effects in human adolescents? Int J Neuropsychopharmacol (2011) 0.84
Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice. Front Cell Neurosci (2013) 0.84
Preliminary evidence for lowered basal cortisol in a naturalistic sample of methamphetamine polydrug users. Exp Clin Psychopharmacol (2012) 0.84
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant mice. PLoS One (2012) 0.84
The synthesis and pharmacological evaluation of adamantane-derived indoles: cannabimimetic drugs of abuse. ACS Chem Neurosci (2013) 0.84
Disruptive effects of the prototypical cannabinoid Δ⁹-tetrahydrocannabinol and the fatty acid amide inhibitor URB-597 on go/no-go auditory discrimination performance and olfactory reversal learning in rats. Behav Pharmacol (2011) 0.84
Reduced sensitivity to MDMA-induced facilitation of social behaviour in MDMA pre-exposed rats. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.83
Moderate alcohol intake is related to increased heart rate variability in young adults: implications for health and well-being. Psychophysiology (2013) 0.83
The first CNS-active carborane: A novel P2X7 receptor antagonist with antidepressant activity. ACS Chem Neurosci (2014) 0.83
The consequences of beer consumption in rats: acute anxiolytic and ataxic effects and withdrawal-induced anxiety. Psychopharmacology (Berl) (2002) 0.83
MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. Brain Res Bull (2011) 0.83
Protein expression profile in the striatum of rats with methamphetamine-induced behavioral sensitization. Proteomics (2007) 0.83
Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues. ACS Chem Neurosci (2016) 0.83
Fear, risk assessment, and playfulness in the juvenile rat. Behav Neurosci (2006) 0.82
Defensive aggregation (huddling) in Rattus norvegicus toward predator odor: individual differences, social buffering effects and neural correlates. PLoS One (2013) 0.82
Exercise increases plasma THC concentrations in regular cannabis users. Drug Alcohol Depend (2013) 0.82
Beer promotes high levels of alcohol intake in adolescent and adult alcohol-preferring rats. Alcohol (2011) 0.81
Lithium carbonate in the management of cannabis withdrawal: a randomized placebo-controlled trial in an inpatient setting. Psychopharmacology (Berl) (2014) 0.81
Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration. Pharmacol Biochem Behav (2006) 0.81
Defensive responses of Wistar and Sprague-Dawley rats to cat odour and TMT. Behav Brain Res (2006) 0.81
The cannabinoid receptor agonist THC attenuates weight loss in a rodent model of activity-based anorexia. Neuropsychopharmacology (2011) 0.81
'When an old rat smells a cat': A decline in defense-related, but not accessory olfactory, Fos expression in aged rats. Neurobiol Aging (2009) 0.81
Benzodiazepines impair the acquisition and reversal of olfactory go/no-go discriminations in rats. Behav Neurosci (2007) 0.81
Rapid quantitation of fluoxetine and norfluoxetine in serum by micro-disc solid-phase extraction with high-performance liquid chromatography-ultraviolet absorbance detection. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.81
MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats. Neuropharmacology (2005) 0.81
Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats. Pharmacol Biochem Behav (2004) 0.80
A double-blind randomized controlled trial of oxytocin nasal spray in Prader Willi syndrome. Am J Med Genet A (2014) 0.80
Give me a hi-5! An additional version of the h-index. Aust N Z J Psychiatry (2013) 0.79
Long-lasting FosB/DeltaFosB immunoreactivity in the rat brain after repeated cat odor exposure. Neurosci Lett (2009) 0.79
Rats discriminate individual cats by their odor: possible involvement of the accessory olfactory system. Neurosci Biobehav Rev (2008) 0.79
Comparative proteomics in the corpus callosal sub-regions of postmortem human brain. Neurochem Int (2009) 0.79
Aggregation in quads but not pairs of rats exposed to cat odor or bright light. Behav Processes (2012) 0.79
Rubbings deposited by cats elicit defensive behavior in rats. Physiol Behav (2012) 0.79
Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). Eur J Neurosci (2009) 0.79
Long-term daily access to alcohol alters dopamine-related synthesis and signaling proteins in the rat striatum. Neurochem Int (2012) 0.78
A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Neurochem Int (2010) 0.78
Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety. Life Sci (2010) 0.78
Sedative and hypothermic effects of gamma-hydroxybutyrate (GHB) in rats alone and in combination with other drugs: assessment using biotelemetry. Drug Alcohol Depend (2009) 0.78
Residual social, memory and oxytocin-related changes in rats following repeated exposure to γ-hydroxybutyrate (GHB), 3,4-methylenedioxymethamphetamine (MDMA) or their combination. Psychopharmacology (Berl) (2010) 0.78
Antipsychotic induced alteration of growth and proteome of rat neural stem cells. Neurochem Res (2012) 0.77
Differential protein expression in the corpus callosum (body) of human alcoholic brain. J Neurochem (2009) 0.77
Neuroadaptations in the striatal proteome of the rat following prolonged excessive sucrose intake. Neurochem Res (2014) 0.77
Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology (Berl) (2003) 0.76
Hippocampal protein expression is differentially affected by chronic paroxetine treatment in adolescent and adult rats: a possible mechanism of "paradoxical" antidepressant responses in young persons. Front Pharmacol (2013) 0.76
Asymmetric suppression of components in binary aldehyde mixtures: behavioral studies in the laboratory rat. Chem Senses (2007) 0.76
WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action. Psychopharmacology (Berl) (2015) 0.76
Oxytocin and MDMA ('Ecstasy') enhance social reward in rats. Psychopharmacology (Berl) (2015) 0.76
Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulation. Behav Brain Res (2002) 0.75
Defensive behavior. Neurosci Biobehav Rev (2005) 0.75
Chronic repetitive transcranial magnetic stimulation is antidepressant but not anxiolytic in rat models of anxiety and depression. Psychiatry Res (2005) 0.75